FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

New Tool to Report Health Care Provider Complaints
July 19, 2016

The Complaint Portal is a way for consumers to find the correct agency to submit health care complaints in an electronic and secure format. Continue reading


FREE Webinars Now Available
July 19, 2016

Learn how to add your license to your Online Services Portal account or report your continuing education/continuing medical education (CE/CME) requirements. Continue reading